Eric Morgen At Ardd2022: Data-Informed Drug Discovery And Clinical Development For Aging Therapies

Eric Morgen at ARDD2022: Data-informed drug discovery and clinical development for aging therapies

ARDD

Dr. Eric Morgen- Data-driven drug discovery and clinical development for therapies that target aging

Longevity Global

Eric Verdin at ARDD2024: Defining and measuring human immune aging

ARDD

Marco Quarta, ARDD2022 from AI enabled discovery of senescense to target senolytic drug development

ARDD

Sara Hägg at ARDD2022: Human biological aging and drug treatment effects

ARDD

Morten Scheibye-Knudsen at ARDD2022: Genome maintenance mechanisms in aging

ARDD

Gordon J Lithgow for the ARDD2022: Chemical interventions in aging promoting Healthspan

ARDD

Dr. Eric Morgen on The BioAge Platform: From Biomarkers to Drug Trials and Back at EARD 2022

Lifespan Extension Advocacy Foundation

Ellen Nollen at ARDD2022: Modifying protein toxicity in ageing and age related diseases

ARDD

Pingze Zhang, ARDD2022: S6K Inhibition benefits age-related immune dysfunctions & increases lifespan

ARDD

Andrea Maier at ARDD2022: Bringing geroscience into clinical practice

ARDD

The BioAge Platform: From biomarkers to drug trials and back again: Eric Morgen, M.D. at EARD 2023

Lifespan Extension Advocacy Foundation

Ann Beliën at ARDD2022: platform based clinical development in aging

ARDD

Alexey Moskalev for the ARDD2022: Omics studies of Drosophila aging and longevity

ARDD

Jonas Hannestad at ARDD2022: Geroprotective effects of the small molecule PGC-1⍺ modulator TQS-168

ARDD

Nir Barzilai at ARDD2022: The genetics of exceptional longevity

ARDD

Joao Pedro de Magalhaes at ARDD2022: Data-driven approaches in longevity pharmacology

ARDD

Steve Horvath at ARDD2024: DNA methylation studies of maximum lifespan in mammals

ARDD

Martin Borch-Jensen at ARDD2022: optimizing translatability of drug discovery for diseases of aging

ARDD